DNAY Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (4 saus. 2023 @ 07:00):

Stats
Šios dienos apimtis	19 945
Vidutinė apimtis	79 397
Rinkos kapitalizacija	38.32M
EPS	$-0.370 ( Q3 \| 2023-11-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 43.86
ATR14	$0.130 (10.00%)

ABMD 0.00%

AMIX -4.95%

BBLGW -21.85%

BVS 0.52%

COCH 3.06%

DHAI -3.26%

DHAIW -22.93%

DNAY 8.33%

EYES -5.05%

GBS -1.58%

HSCS -1.70%

HSCSW -32.26%

IINNW 1.61%

INVO -3.33%

LFWD 1.26%

MDAI -2.22%

MGRM 3.86%

MXCT -2.00%

NVNOW -32.98%

NXL -42.91%

NXLIW -15.00%

OSA -7.35%

OSAAW -6.40%

PAVMW 105.67%

PAVMZ 0.00%

PETVW 0.00%

QTI 2.21%

QTNT 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-08-31	Kullback William J	Buy	300 000	Stock Option (right to buy)
2023-08-28	Kullback William J	Buy	0
2023-10-18	Herrema Gregory J.	Buy	229 787	Stock Option (right to buy)
2023-10-18	Herrema Gregory J.	Buy	153 191	Common Stock
2023-10-18	Herrema Gregory J.	Buy	0

INSIDER POWER
96.64
Last 81 transactions
Buy: 30 855 803 \| Sell: 22 356 163

Tūris Koreliacija

Ilgas: 0.34 (neutral)

Trumpas: -0.56 (weak negative)

Signal:(51.007) Neutral

Codex DNA, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Codex DNA, Inc. Koreliacija - Valiuta/Žaliavos

0.60
( weak )

-0.60
( weak negative )

0.00
( neutral )

0.28
( neutral )

0.60
( weak )

-0.50
( weak negative )

Codex DNA, Inc. Finansinės ataskaitos

Annual	2022
Pajamos:	$27.44M
Bruto pelnas:	$15.60M (56.84 %)
EPS:	$-1.640

FY	2022
Pajamos:	$27.44M
Bruto pelnas:	$15.60M (56.84 %)
EPS:	$-1.640

FY	2021
Pajamos:	$11.04M
Bruto pelnas:	$4.30M (38.93 %)
EPS:	$-1.828

FY	2020
Pajamos:	$6.58M
Bruto pelnas:	$3.63M (55.12 %)
EPS:	$-0.820

Financial Reports:

No articles found.

Codex DNA, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Codex DNA, Inc.

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.